Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to conduct a randomized clinical trial to evaluate an opioid
versus an opioid-free pathway of perioperative use of ketamine, ketorolac, and IV
acetaminophen followed by the postoperative use of ketorolac, and oral acetaminophen for pain
associated with robotic-assisted radical prostatectomy. Escalation to use of opioid treatment
for the opioid-free constituents will be available if needed.